Construction to begin on new air ambulance base that will 'save lives'
The Hampshire and Isle of Wight Air Ambulance's new airbase, on George Curl Way, near Southampton Airport, is set to undergo construction ahead of its opening next Spring.
This moves the charity from its current airbase in Thruxton, Andover, to a more central part of the region and will dramatically improve response times for the majority of the missions.
Clinical lead Simon Hughes said: "It is going to transform what we do going forward.
"In those life-threatening situations, literally seconds count, so being able to shave off time is going to save more lives."
Simon Hughes (Image: Cristiano Magaglio)
Teams will be able to reach almost every patient in the region within 10 minutes of take-off.
In fact, during the press event, one of the air ambulance's land vehicles was called to an incident; its sirens could be heard as it immediately found its way onto the motorway from the base.
Senior paramedic lead Pat Andrews has been with the charity since it started 18 years ago. He said: "This is going to make a massive difference for us."
READ MORE: Hundreds of extra school spaces expected in Southampton as birth rate drops
Pat Andrews (Image: Cristiano Magaglio)
Pat adds that the new centre would mean that the service could attend an incident on the Isle of Wight in just 15 minutes, as opposed to the current 25.
So far, more than £1.6 million has been donated towards the build, with a further £2 million needed.
The air ambulance charity has appointed local building contractors Rosewood Building Services to convert the current building into a purpose-built airbase.
Chair of the charity, Rebecca Brackwell-Slade (Image: Cristiano Magaglio)
Chair of the charity, Rebecca Brackwell-Slade said: "We are so excited. It feels quite surreal to be here today.
"It is in an optimal location. In many ways, it was an immediate front runner from when we saw it."
READ MORE: We go inside Hampshire and Isle of Wight Air Ambulance Thruxton HQ
Handover of the key to the developer (Image: Cristiano Magaglio)
It is hoped that the charity's doctors, pilots and paramedics will be fully operational from the new base in March.
The 4,273 square metre, two-storey site will feature a hangar to house the helicopter, a helipad, office space, aftercare facilities, on-site crew accommodation, training and briefing rooms and a garage for the charity's fleet of emergency response vehicles.
The back of the building, where the helipad will be built (Image: Cristiano Magaglio)
A dedicated visitor centre which overlooks the helipad will provide a space for the charity's community CPR and AED training.
Richard Corbett, Hampshire and Isle of Wight Air Ambulance CEO, said: 'Every step we take towards our goal of moving into our new home is hugely significant.
'A huge thank you to everyone whose kindness and generosity has turned this long-held dream for the charity into a reality.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Plexāā Closes $4.5 Million Funding Extension to Drive U.S. Launch of BLOOM43 Platform for Breast Surgery
LONDON--(BUSINESS WIRE)--Jul 8, 2025-- Plexāā, a MedTech startup behind the award-winning BLOOM 43 medical device for breast surgery, has announced the close of a $4.5 million funding extension round. The strategic capital infusion will support the imminent U.S. launch of BLOOM 43, while also laying the groundwork for future innovations. The funding also strengthens the company's position ahead of their planned Series A fundraising round. Complication rates in breast surgeries, which can include infection, skin necrosis and the need for additional surgeries, have been recorded as high as 30 percent. 1 BLOOM 43 is the world's first fully wearable medical device designed to help patients prepare for breast cancer surgery and reconstruction by harnessing the power of Supraphysiological Preconditioning ™. The new technique safely and intermittently thermally preconditions the skin causing the release of heat-shock proteins that cause vasodilation and increased blood flow to the area. This process has been shown to reduce wound healing complications in proof-of-concept clinical trials. Along with its BLOOM 43 companion app, the device has demonstrated substantial improvements in the patient experience and surgical readiness, harnessing the power of holistic Prehabilitation ™ and preconditioning. The company has already secured multiple partners for its upcoming U.S. commercial launch. 'I want to thank our team for the tremendous progress it has made to make this financing possible,' said Dr. Saahil Mehta, founder and CEO of Plexāā. 'Securing this funding validates confidence in our flagship technology and the concept of Supraphysiological Preconditioning ™, and it energizes the team as we prepare to bring BLOOM 43 to a wider patient population in the U.S. and beyond. The funds will support this pivotal launch and market expansion, as well as the exciting development of our technology platform – including devices and apps targeting additional surgical specialties and creating a whole new category in surgery.' Plexāā Ltd has been backed by TCP Health Ventures (the dedicated healthcare investment arm of The Capital Partnership group of companies) who led the Seed Round. This extension round comprises existing and new investors including TCP. Further investment includes over $1.6 million in i4i grant funding from the National Institute for Health and Care Research (NIHR), and $1.3 million from Thena Capital, a London-based VC firm backed by the British Business Bank and focused on digital health and fast-tracked Medtech. Tatum Getty, founding General Partner at THENA Capital added, 'Since 2023, we've been closely tracking Plexāā's progress and the development of its first device, BLOOM 43. We couldn't be more excited for Plexāā to become our first portfolio company for THENA Capital's Fund I. The company is solving a critical and under-addressed challenge across the surgical pathway- reducing post-operative complications for patients which also addresses the impact to both providers and payers. 'Saahil and his team bring together clinical, engineering, and operational expertise from some of the UK's leading institutions. Their bold ambition to scale globally, beginning with an imminent commercial launch in the U.S., is exactly the kind of UK MedTech leadership team we look to champion. Our fund's commercialisation support model is well-suited to help Plexāā expand into women's health and adjacent categories where better outcomes and patient experiences are urgently needed.' Plexāā plans to collaborate with clinicians, patients, and partners worldwide to make prehabilitation and preconditioning the standard of care for surgery — and to deliver transformative solutions that address unmet needs in surgical care. About Plexāā Plexāā is a pioneering UK-based MedTech company focused on improving surgical outcomes through devices and digital products. Its flagship device, BLOOM 43, enables patients to supraphysiologically precondition their skin, potentially reducing the risk of wound healing complications such as infection and skin necrosis, which affect one in three women undergoing breast surgery. Plexāā is also exploring the application of this technology in other surgical fields, including obstetrics for C-sections, orthopaedics for joint operations, and general and vascular surgery, with a commitment to improving pre-operative preparation for surgery and patient outcomes. About TCP Health Ventures TCP Health Ventures is the dedicated healthcare investment arm of The Capital Partnership group of companies, a multi-asset investment company with assets under management of $7 billion. Headquartered out of London, TCP Health Ventures manages assets of $ 225 million across 15+ investments in the med-tech space and has a med-tech investing experience of 10 years. About the NIHR The mission of the National Institute for Health and Care Research (NIHR) is to improve the health and wealth of the nation through research. We do this by: NIHR is funded by the Department of Health and Social Care. Its work in low- and middle- income countries is principally funded through UK international development funding from the UK government. About THENA Capital THENA Capital is a London-based venture capital firm backing the world's next category-defining medical technologies. We invest in breakthrough companies transforming care experiences through digital health, fast-tracked medical devices, and clinical-grade innovation. THENA's debut Fund 1, focuses on high-impact, UK-founded technologies addressing unmet needs across women's health, oncology, cardiovascular disease, chronic conditions, and care delivery. With deep clinical, regulatory and operational expertise, THENA Capital partners with founders to unlock international scale, navigate complex markets, and build enduring category leaders in global healthcare. References 1 Annals of Translational Medicine, Dec 2023, Management of complications following implant-based breast reconstruction: a narrative review, Dean H. Meshkin 1^, Joseph M. Firriolo 1, Nolan S. Karp 2, Ara A. Salibian 1 View source version on CONTACT: Media Contacts: Sam Choinski Pazanga Health Communications [email protected] (860) 301-5058 [email protected] KEYWORD: EUROPE UNITED STATES UNITED KINGDOM NORTH AMERICA NEW YORK INDUSTRY KEYWORD: TECHNOLOGY BIOTECHNOLOGY HEALTH CONSUMER APPS/APPLICATIONS SURGERY PROFESSIONAL SERVICES ONCOLOGY MEDICAL DEVICES SOFTWARE DATA ANALYTICS HEALTH TECHNOLOGY WOMEN DATA MANAGEMENT SOURCE: Plexāā Copyright Business Wire 2025. PUB: 07/08/2025 03:46 PM/DISC: 07/08/2025 03:46 PM
Associated Press
4 hours ago
- Associated Press
Transforming Healthcare Ltd Launches the Healthcare Convergence Framework: A Pioneering AI/Robotics Readiness Assessment Tool for Healthcare
London, UK , July 08, 2025 (GLOBE NEWSWIRE) -- Transforming Healthcare Ltd, a leader in healthcare consultancy and innovation, has announced the global launch of the Healthcare Convergence Framework® (HCF), the world's first AI/Robotics Readiness Assessment Tool specifically designed for healthcare organisations. Developed by the esteemed physician and thriving healthcare strategist Dr. Pietro Emanuele Garbelli, this groundbreaking framework is set to revolutionise the way hospitals, clinicians, and decision-makers evaluate their preparedness for integrating artificial intelligence and robotics into patient care, governance, and clinical operations. The Healthcare Convergence Framework® AI/Robotics Assessment tool arrives at a pivotal moment in the healthcare industry, where the acceleration of AI technologies demands strategic, clinician-led implementation. This tool empowers healthcare organisations to assess their readiness while safeguarding the ethics, trust, and human essence of medicine. By providing a comprehensive evaluation, the HCF ensures that healthcare providers can navigate the complexities of AI integration with confidence and foresight. 'The launch of the Healthcare Convergence Framework® marks a significant milestone in our mission to enhance care quality and reduce systemic inefficiencies,' said Dr. Pietro Emanuele Garbelli, CEO of Transforming Healthcare Ltd. 'This tool is not just about technology readiness; it's about ensuring that the integration of AI and robotics is done ethically and with a focus on maintaining the human touch in medicine.' The tool is now publicly accessible via providing healthcare leaders and decision makers with an invaluable resource to guide their strategic planning and operational readiness. As AI continues to transform the healthcare landscape, the HCF offers a structured approach to embracing these advancements responsibly and effectively. Transforming Healthcare Ltd, founded by Dr. Garbelli, is dedicated to shaping intelligent, ethical, and future-ready healthcare systems. Through strategic frameworks like the Healthcare Convergence Framework® and high-impact advisory, the company empowers healthcare organisations, clinicians, and healthcare leaders and decision-makers to lead with clinical excellence in the digital age. Dr Pietro Emanuele Garbelli About Transforming Healthcare Ltd Transforming Healthcare Ltd is a forward-thinking consultancy and innovation company dedicated to shaping intelligent, ethical, and future-ready healthcare systems. Founded by Dr. Pietro Emanuele Garbelli, the company empowers hospitals, clinicians, and healthcare leaders to navigate the evolving intersection of medicine, AI, and robotics. Through strategic frameworks, like the Healthcare Convergence Framework®, and high-impact advisory, Transforming Healthcare Ltd helps organisations enhance care quality, reduce systemic inefficiencies, and lead with clinical excellence in the digital age. Press inquiries Transforming Healthcare Ltd Pietro Emanuele Garbelli [email protected] 07517463999 20-22 Wenlock Road London N1 7GU United Kingdom
Yahoo
5 hours ago
- Yahoo
NHS disruption expected as resident doctors vote for strike action
The NHS could face six months of disruption after resident doctors in England voted in favour of strike action. Downing Street said pay negotiations will not be reopened because the Government 'can't be more generous' than it has been already this year. The ballot gives resident doctors a mandate for strike action until January 2026. Some 90% of voting resident doctors in England, formerly known as junior doctors, said they would down their stethoscopes and take to picket lines amid an ongoing row over pay. The British Medical Association (BMA) said there was a turnout of 55%. The union has said resident doctors need a pay uplift of 29.2% to reverse 'pay erosion' since 2008/09. Health Secretary Wes Streeting said it was 'disappointing' that medics were threatening strike action, saying that the 'majority of resident doctors did not vote to strike'. BMA resident doctors committee co-chairs Dr Melissa Ryan and Dr Ross Nieuwoudt said in a statement: 'All we need is a credible pay offer and nobody need strike. 'Doctors don't take industrial action lightly – but they know it is preferable to watching their profession wither away. 'The next move is the Government's. 'Will it repeat the mistakes of its predecessor? Or will it do the right thing and negotiate a path to full pay restoration and the restoration of doctors' confidence in our profession's future?' The results are in: we have a clear mandate to strike. More than 90% of you who voted in our ballot, voted YES. You've made it clear: enough is enough. Our fight for full #PayRestoration for resident doctors in England continues. — Resident Doctors (@BMAResidents) July 8, 2025 Mr Streeting said: 'While the majority of resident doctors did not vote to strike, it is disappointing that the BMA are threatening strike action that would harm patients and set back all the progress we're making with the NHS. 'Thanks to this Government, resident doctors have received a 28.9% pay rise compared to three years ago, and the highest pay award of the entire public sector this year. 'I met with the BMA today, and while we can't go further on pay than we already have this year, I offered to work with them to resolve issues they face around working conditions. These are not grounds for strike action. My offer to meet their entire committee remains open.' A Number 10 spokesman said: 'We aren't going to reopen negotiations on pay. 'Resident doctors have received the highest pay award across the public sector for two years in a row, and we've been clear that we can't be more generous than we already have this year.' A fresh bout of walkouts could cause severe upheaval across the health service. Previous strikes by resident doctors and other staff groups saw some 1.5 million appointments, procedures and operations postponed as a result. The news will come as a blow to the Government after Prime Minister Sir Keir Starmer's 'plan for change' pledged that by July 2029, 92% of patients will be seen within 18 weeks for routine hospital treatment such as hip and knee replacements. The waiting list for routine hospital treatment in England is currently at its lowest level for two years, according to the latest figures, with an estimated 7.39 million treatments waiting to be carried out at the end of April. Danny Mortimer, chief executive of NHS Employers, which is part of the NHS Confederation, said: 'Further strikes are the last thing health leaders wanted and could result in tens, if not hundreds, of thousands of operations and procedures being delayed or cancelled, leaving patients in pain or discomfort.' Daniel Elkeles, chief executive of NHS Providers, said: 'A return to industrial action would be a huge setback – bad for patients, for staff and for the NHS.' In September, BMA members voted to accept a Government pay deal worth 22.3% on average over two years. And the 2025/26 pay deal saw resident doctors given a 4% uplift plus £750 'on a consolidated basis' – working out as an average pay rise of 5.4%. The BMA call for a 29.2% uplift is based on Retail Prices Index (RPI) inflation, the measure of average changes in the price of goods and services used by most households. Edward Argar, shadow health secretary, said: 'We warned Labour that caving in to union demands for above-inflation pay rises without conditions would set a dangerous precedent and that the unions would simply come back for more. 'That warning has sadly become true with today's strike vote. Calling all resident doctors in England 📢 It's your last chance to vote YES to #PayRestoration and guarantee it's counted. All votes must be received before the ballot closes on 7 July. — Resident Doctors (@BMAResidents) June 30, 2025 'We are now staring down the barrel of a summer of strikes.' There are around 77,000 resident doctors in England who work in various settings from GP surgeries to hospitals. Resident doctor is a catch-all term for all doctors in training, ranging from graduates to medics with a decade of experience. Resident doctor members of the BMA have taken industrial action 11 times since 2022.
